Pharma companies and academic institutions in multiple countries sign up to Symcel’s ground-breaking isothermal microcalorimetry label free well plate assay technology
2 June 2015: SymCel, the company behind the revolutionary cell-based assay tool providing real time cellular bioenergetics measurements, is pleased to announce that its ground-breaking calScreener™ technology has secured nine installations across five different countries for a mixture of university institutions and pharmaceutical companies. To date, the geographic spread includes, four signings in Sweden, two signings in Switzerland, and one each in Holland, South Africa, Germany and South East Asia
The announcement of the geographic roll-out of calScreener™ follows the recent publication in The Biotechnology Journal of published scientific data showing that CalScreener provides novel insights in the study of tumorous micro tissues, bacteria and parasitic worms, whilst providing continuous real-time biological data.
In Sweden, the technology is being put to use for assay testing in metabolic research, therapeutic antibody development, malaria and fresh water quality, whilst in Germany, the calScreener™ is being utilised for toxicology testing. Moreover, in Holland the tool is being applied in bacterial and biofilm development for the treatment of bacterial infections with antibiotics. Furthermore, the assay technology is being used in the field of turberculosis in South Africa, tropical parasites in Switzerland and metabolic research in South East Asia.
Commenting on the increasing uptake of calScreener™ in multiple coutries for a wide range of applications, Christer Wallin, the CEO of Symcel said: “We are very pleased that the life science community is taking advantage of our innovative calScreener™ technology for highly accurate and reliable assay testing. In particular, we are pleased by the sheer range of applications in which researchers and scientists are making strong use of our technology.”
The SymCel website address as requested: http://www.symcel.se/.
SymCel Company Info
SymCel provides a novel cell-based assay tool for real time cellular bioenergetics measurements. SymCel is a privately held biotechnology company located in the Kista region of Stockholm Sweden, a region well known for high tech telecom and med-tech industry development.
SymCel was founded by Dr Dan Hallen and Prof. Ingemar Wadsö in 2004. The founders have an extensive background in the field of calorimetry measurement and technology development. The current research team at SymCel has over 62 years of experience from many disciplines within the biotechnology industry as well as the pharmaceutical development industry.
SymCel develops and markets analytical instrumentations that fulfil an unmet need for cell biological research and development, within R&D departments of Life Science industry, as well as academic research laboratories. Our solution is a fast label-free assay technology providing real-time continuous data monitoring of cell metabolism.
For media enquiries, please contact Tristan Jervis on +44 (0) 207 203 6740 or e-mail: t.jervis@defacto.com.
Help employers find you! Check out all the jobs and post your resume.
2 June 2015: SymCel, the company behind the revolutionary cell-based assay tool providing real time cellular bioenergetics measurements, is pleased to announce that its ground-breaking calScreener™ technology has secured nine installations across five different countries for a mixture of university institutions and pharmaceutical companies. To date, the geographic spread includes, four signings in Sweden, two signings in Switzerland, and one each in Holland, South Africa, Germany and South East Asia
The announcement of the geographic roll-out of calScreener™ follows the recent publication in The Biotechnology Journal of published scientific data showing that CalScreener provides novel insights in the study of tumorous micro tissues, bacteria and parasitic worms, whilst providing continuous real-time biological data.
In Sweden, the technology is being put to use for assay testing in metabolic research, therapeutic antibody development, malaria and fresh water quality, whilst in Germany, the calScreener™ is being utilised for toxicology testing. Moreover, in Holland the tool is being applied in bacterial and biofilm development for the treatment of bacterial infections with antibiotics. Furthermore, the assay technology is being used in the field of turberculosis in South Africa, tropical parasites in Switzerland and metabolic research in South East Asia.
Commenting on the increasing uptake of calScreener™ in multiple coutries for a wide range of applications, Christer Wallin, the CEO of Symcel said: “We are very pleased that the life science community is taking advantage of our innovative calScreener™ technology for highly accurate and reliable assay testing. In particular, we are pleased by the sheer range of applications in which researchers and scientists are making strong use of our technology.”
The SymCel website address as requested: http://www.symcel.se/.
SymCel Company Info
SymCel provides a novel cell-based assay tool for real time cellular bioenergetics measurements. SymCel is a privately held biotechnology company located in the Kista region of Stockholm Sweden, a region well known for high tech telecom and med-tech industry development.
SymCel was founded by Dr Dan Hallen and Prof. Ingemar Wadsö in 2004. The founders have an extensive background in the field of calorimetry measurement and technology development. The current research team at SymCel has over 62 years of experience from many disciplines within the biotechnology industry as well as the pharmaceutical development industry.
SymCel develops and markets analytical instrumentations that fulfil an unmet need for cell biological research and development, within R&D departments of Life Science industry, as well as academic research laboratories. Our solution is a fast label-free assay technology providing real-time continuous data monitoring of cell metabolism.
For media enquiries, please contact Tristan Jervis on +44 (0) 207 203 6740 or e-mail: t.jervis@defacto.com.
Help employers find you! Check out all the jobs and post your resume.
